By a News Reporter-Staff News Editor at Women’s Health Weekly -- New research on Tumor Virus Infections - Papillomavirus Infections is the subject of a report. According to news reporting originating from Guangzhou, People’s Republic of China, by NewsRx correspondents, research stated, “To estimate the impact of human papillomavirus (HPV) infection on spontaneous abortion, spontaneous preterm birth (sPTB), pregnancy rate of females undergoing assisted reproductive technologies (ART), and spontaneous abortion of ART pregnancy. PubMed, Medline, Embase, and the Cochrane Library were searched until December 16, 2016.”
Our news editors obtained a quote from the research from Southern Medical University, “The OR or relative risk (RR) with its corresponding 95% CI were selected as effect size. Subgroup analysis of HPV genotype infection (high-risk HPV [HR-HPV] or indiscriminate genotype) was performed. Statistical analysis was conducted using STATA 12.0. Eighteen studies were included. Eight studies revealed no significant association between HPV infection and spontaneous abortion (OR 1.40, 95% CI 0.56-3.50). However, subgroup analysis showed indiscriminate genotype HPV infection increased the ratio of spontaneous abortion with OR of 2.24 (95% CI 1.37-3.65), while HR-HPV infection had no significant effect (OR 0.65, 95% CI 0.21-1.98). The results indicated that HR-HPV infection was a risk for sPTB with a pooled OR of 2.84 (95% CI 1.95-4.14). HPV infection was found to be independent of the ART-based clinical pregnancy rate (RR 1.04, 95% CI 0.64-1.70) and spontaneous abortion of ART pregnancy (RR 1.47, 95% CI 0.86-2.50). Indiscriminate HPV genotype infection can increase the risk of spontaneous abortion and HR-HPV infection was a risk factor for sPTB. However, there was not enough evidence to indicate the association between HPV infection and pregnancy rate of ART, and spontaneous abortion of ART pregnancy.”
According to the news editors, the research concluded: “Different genotypes of HPV infection may play a discrepant role in adverse pregnancy outcomes.”
For more information on this research see: The Risk of Human Papillomavirus Infection for Spontaneous Abortion, Spontaneous Preterm Birth, and Pregnancy Rate of Assisted Reproductive Technologies: A Systematic Review and Meta-Analysis. Gynecologic and Obstetric Investigation , 2018;():. (Karger - http://www.karger.com/; Gynecologic and Obstetric Investigation - http://content.karger.com/ProdukteDB/produkte.asp?Aktion=JournalHome&ProduktNr=223845)
The news editors report that additional information may be obtained by contacting Y.Q. Xiong, Dept. of Epidemiology, School of Public Health, Guangdong Provincial Key Laboratory of Tropical Disease Research, Southern Medical University, Guangzhou, People’s Republic of China. Additional authors for this research include Y. Mo, Q.M. Luo, S.T. Huo, W.Q. He and Q. Chen.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC
CITATION: (2018-04-26), Studies from Southern Medical University Have Provided New Data on Papillomavirus Infections (The Risk of Human Papillomavirus Infection for Spontaneous Abortion, Spontaneous Preterm Birth, and Pregnancy Rate of Assisted Reproductive ...), Women’s Health Weekly, 385, ISSN: 1532-4729, BUTTER® ID: 015526714
From the newsletter Women’s Health Weekly.
https://www.newsrx.com/Butter/#!Search:a=15526714
This is a NewsRx® article created by NewsRx® and posted by NewsRx®. As proof that we are NewsRx® posting NewsRx® content, we have added a link to this steemit page on our main corporate website. The link is at the bottom left under "site links" at https://www.newsrx.com/NewsRxCorp/.
We have been in business for more than 20 years and our full contact information is available on our main corporate website.
We only upvote our posts after at least one other user has upvoted the article to increase the curation awards of upvoters.
NewsRx® offers 195 weekly newsletters providing comprehensive information on all professional topics, ranging from health, pharma and life science to business, tech, energy, law, and finance. Our newsletters report only the most relevant and authoritative information from qualified sources.